Key facts
- IRegained’s last known valuation is $12.0M (Sep 2025).
- It has raised $4.2M; the latest was Later Stage VC ($300K) in Dec 2025.
- Notable investors include Creative Destruction Lab, University of Toronto, Mayo Clinic, Innovation Factory (Hamilton), CABHI — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for IRegained
- ·The full record, as it builds
Funding rounds
No funding rounds for IRegained are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IRegained
Developer of medical devices designed to address the physical rehabilitation needs of individuals. The company's products assist people who have experienced an injury to the brain through stroke or trauma, resulting in impairment in hand function, enabling stroke patients to regain both control and hand function.
- Sector
- Healthcare
- HQ
- Sudbury, Canada
- Founded
- 2016
- Employees
- 7
- Website
- iregained.rehab/
- Ownership
- Privately Held (backing)
IRegained doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IRegained shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IRegained in its N-PORT filings yet. We sweep new filings monthly.